Description
Product: TAFINLAR
Manufacturer: GlaxoSmithKline
Generic: Dabrafenib
Type: Capsules
Strength: 50mg & 75mg
Packing: 120 Capsules
Description: This drug is used inhibitor of some mutated forms of BRAF kinases, as well as wild-type BRAF and CRAF kinases. Some mutations in the BRAF gene, including those that result in BRAF V600E, can result in constitutively activated BRAF kinases that may stimulate tumor cell growth.
Reviews
There are no reviews yet.